This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Vaginal vs. Laparoscopic Hysterectomy

This study is ongoing, but not recruiting participants.
Austrian Urogynecology Working Group (AUWG)
Information provided by (Responsible Party):
Medical University of Graz Identifier:
First received: February 10, 2014
Last updated: April 26, 2017
Last verified: April 2017

Hysterectomy for benign indication is one of the most common surgical procedures in women. Numerous reviews and guidelines recommend the vaginal approach for benign hysterectomy, but the proportion of laparoscopic (and robotic) hysterectomies is increasing.

This study will compare a range of clinical and subjective outcomes of vaginal vs. total laparoscopic hysterectomy. Outcomes include operating time, postoperative recovery, return to work as well as cosmesis, quality of life and sexual health.

Condition Intervention
Uterine Fibroids Uterine Leiomyoma Abnormal Uterine Bleeding, Unspecified Procedure: Hysterectomy

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Vaginal Hysterectomy Versus Total Laparoscopic Hysterectomy for Benign Indications: A Randomized Controlled Trial

Resource links provided by NLM:

Further study details as provided by Medical University of Graz:

Primary Outcome Measures:
  • Operating time (min.) [ Time Frame: Surgery ]
    Operating time (min.)

Secondary Outcome Measures:
  • Complications [ Time Frame: 6 weeks ]
    Intraoperative and postoperative complications

  • Anesthesia time (min.) [ Time Frame: surgery ]
  • Quality of life [ Time Frame: 12 months ]
  • Sexual health [ Time Frame: 12 months ]
  • Return to work [ Time Frame: 3 months ]

Enrollment: 100
Study Start Date: January 2014
Estimated Study Completion Date: September 2017
Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Vaginal hysterectomy
Vaginal hysterectomy
Procedure: Hysterectomy
Active Comparator: Total laparoscopic hysterectomy
Laparoscopic hysterectomy
Procedure: Hysterectomy


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • benign indication for vaginal hysterectomy (e.g., abnormal uterine bleeding, fibroids, atypical endometrial hyperplasia)
  • clinical exam indicates vaginal hysterectomy is feasible
  • no major concomitant surgery
  • able to complete questionnaires in German

Exclusion Criteria:

  • uterine malignancy
  • major concomitant surgery (e.g., for incontinence or prolapse)
  • clinical exam indicating vaginal hysterectomy not feasible
  • contraindication for surgery or laparoscopy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT02059954

Krankenhaus der Barmherzigen Brüder, Abteilung Gynäkologie
Graz, Austria, 8020
Medical University of Graz/Dept. OB/GYN
Graz, Austria, 8036
LKH Leoben/Abteilung Gynäkologie
Leoben, Austria, 8700
Sponsors and Collaborators
Medical University of Graz
Austrian Urogynecology Working Group (AUWG)
Study Chair: Karl F Tamussino, MD Medical University of Graz
Principal Investigator: Rene W Laky, MD Medical University of Graz
  More Information

Responsible Party: Medical University of Graz Identifier: NCT02059954     History of Changes
Other Study ID Numbers: 26-122 ex 13/14
MUG 26-122 ex 13/14 ( Other Identifier: MUGraz )
Study First Received: February 10, 2014
Last Updated: April 26, 2017

Keywords provided by Medical University of Graz:

Additional relevant MeSH terms:
Uterine Hemorrhage
Neoplasms, Muscle Tissue
Neoplasms, Connective and Soft Tissue
Neoplasms by Histologic Type
Neoplasms, Connective Tissue
Connective Tissue Diseases
Uterine Diseases
Genital Diseases, Female
Pathologic Processes processed this record on September 20, 2017